EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

EXPRESSION OF EGFR, ALK, AND ROS1 BY IMMUNOHISTOCHEMISTRY AND THEIR MOLECULAR ALTERATIONS IN NON-SMALL CELL LUNG CARCINOMA

Dr Memoona Kokab, Dr Aima Zahid, Dr Noreen Javaid, Dr Azra Akhtar, Ayesha Sajjad, Aisha Jamil

Genetics and Molecular Research · 06.05.2026

DOI: 10.4238/56r4a581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 06.05.2026. Verfasst von Dr Memoona Kokab und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-small cell lung carcinoma is the most common type of lung cancer and remains a major cause of cancer-related mortality worldwide.

Objective

To assess the expression of EGFR, ALK, and ROS1 by immunohistochemistry and evaluate their molecular alterations in patients with non-small cell lung carcinoma. Methodology: This cross-sectional study was conducted at Pathology Department ( Histopathology section) of Fauji Foundation Hospital Lahore, from February 2025 to December 2025, including 65 patients with histopathologically confirmed non-small cell lung carcinoma. Demographic and clinicopathological data including age, gender, smoking history, histological subtype, tumor grade, and stage were recorded.

Results

The mean age of the patients was 59.4 ± 10.7 years, and 42 (64.6%) were male. Smoking history was present in 41 (63.1%) patients. Adenocarcinoma was the most common histological subtype, seen in 37 (56.9%) cases. Immunohistochemical expression of EGFR, ALK, and ROS1 was observed in 24 (36.9%), 7 (10.8%), and 5 (7.7%) patients, respectively. Molecular analysis showed EGFR mutations in 20 (30.8%) cases, ALK rearrangements in 6 (9.2%), and ROS1 alterations in 4 (6.2%).

Conclusion

EGFR was the most frequently expressed and altered biomarker in non-small cell lung carcinoma, followed by ALK and ROS1.

Zitieren

APA

Kokab, D. M., Zahid, D. A., Javaid, D. N., Akhtar, D. A., Sajjad, A., & Jamil, A. (2026). EXPRESSION OF EGFR, ALK, AND ROS1 BY IMMUNOHISTOCHEMISTRY AND THEIR MOLECULAR ALTERATIONS IN NON-SMALL CELL LUNG CARCINOMA. Genetics and Molecular Research. https://doi.org/10.4238/56r4a581

Vancouver

Kokab DM, Zahid DA, Javaid DN, Akhtar DA, Sajjad A, Jamil A. EXPRESSION OF EGFR, ALK, AND ROS1 BY IMMUNOHISTOCHEMISTRY AND THEIR MOLECULAR ALTERATIONS IN NON-SMALL CELL LUNG CARCINOMA. Genetics and Molecular Research. 2026. doi:10.4238/56r4a581

BibTeX
@article{Kokab2026,
  author = {Kokab, Dr Memoona and Zahid, Dr Aima and Javaid, Dr Noreen and Akhtar, Dr Azra and Sajjad, Ayesha and Jamil, Aisha},
  title = {EXPRESSION OF EGFR, ALK, AND ROS1 BY IMMUNOHISTOCHEMISTRY AND THEIR MOLECULAR ALTERATIONS IN NON-SMALL CELL LUNG CARCINOMA},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/56r4a581}
}
Kostenlos starten →